Posted in | News | Solar Energy | Green Energy

SunEdison and JIC Capital Enter into Joint Venture Agreement

SunEdison, Inc., a leading solar developer and technology provider, announced today a joint venture agreement with JIC Capital, to facilitate nonrecourse financing and develop, construct and own up to 1 GW of utility-scale solar photovoltaic (PV) projects in China over the next 3 years.

The joint venture will focus on facilitating and structuring nonrecourse financing for solar PV plants in one of the world's largest and most attractive solar markets. SunEdison, directly or through an affiliate, including a yieldco, may purchase the projects developed by the joint venture at fair market value.

"This historic joint venture is a great step forward for SunEdison," said Ahmad Chatila, President and CEO of SunEdison. "It is a great honor to partner with a leader like JIC Capital, and we are committed to harnessing our world leading technology and deployment capabilities to deliver clean, cost effective solar energy to the people of China."

"Capital contributions will accelerate the growth of the solar market in China, and China's solar PV industry requires international know-how to improve. We see this collaboration brings opportunities to combine capital and industry, to form a focused industrial investment platform for long-term operations," said Mr. JianPing ZHANG, Chairman, JIC Capital.

China has approximately 19 GW of installed solar energy capacity, with a target to reach 35 GW by 2015 and 100 GW by 2020. The joint venture is currently exploring and evaluating several large-scale projects and expects to start construction in early 2015. Operation and maintenance of the solar power plants will be performed by the SunEdison Renewable Operation Center (ROC), which provides global 24/7 asset management, monitoring and reporting services.

About SunEdison
SunEdison is a global leader in transforming how energy is generated, distributed and owned. SunEdison manufactures solar technology and develops, finances, installs and operates distributed solar power plants, delivering predictably priced electricity and services to its residential, commercial, government and utility customers. SunEdison also provides 24/7 asset management, monitoring and reporting services for hundreds of solar systems worldwide via the company's Renewable Operation Center (ROC). SunEdison has offices in North America, Europe, Latin America, Africa and Asia. SunEdison's common stock is listed on the New York Stock Exchange under the symbol "SUNE." To learn more visit www.sunedison.com.

About JIC Capital
JIC Capital is an asset management company which operates under China Jianyin Investment Corporation (JIC), a wholly owned subsidiary of Central HuiJin Investment Ltd. JIC Capital is a top tier and active private equity investment player in China with the value creation investment philosophy. It specializes in utilizing global resources and professional expertise to focus on investment management, investment banking, financial advisory and private equity fund operations including industrial funds, venture capital funds, buyout funds, and mezzanine funds, etc.

About China Jianyin Investment Corporation
China Jianyin Investment Limited ("JIC") is a wholly owned subsidiary of Central HuiJin Investment Ltd. which was founded in 2004. It is approved by the State Council and is recognized as a first-class domestic investment institution with extraordinary international influence and outstanding performance in both financial and industry sector investment. Focusing on equity investment and industrial management, JIC is an integrated investment group that possesses a complete set of investment systems. Its major businesses operate across fields including investment, finance, real estate, technology and consulting, culture and media.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.